{
 "topic": "Obstructive Sleep Apnea",
 "slug": "obstructive-sleep-apnea",
 "category_id": 15628,
 "summary": "Recognizing pediatric OSAS from history and exam, confirming it with polysomnography and AHI criteria, and the adenotonsillectomy-to-CPAP treatment pathway and its overlap with asthma.",
 "written_by": "claude-sonnet",
 "references": [
  {
   "title": "The Harriet Lane Handbook 22nd Edition (2020) (The Johns Hopkins Hospital)",
   "author": null,
   "pages": [
    772
   ]
  },
  {
   "title": "The Harriet Lane Handbook (The Johns Hopkins Hospital)",
   "author": null,
   "pages": [
    772
   ]
  },
  {
   "title": "AAP Developmental and Behavioral Pediatrics",
   "author": "AAP Section on Developmental and Behavioral Pediatrics,Robert G. Voigt,Michelle M. Macias ,Scott M. Myers ,Carl D Tapia",
   "pages": [
    138
   ]
  },
  {
   "title": "Ghai Essential Pediatrics, 9e (Vinod K Paul, Arvind Bagga)",
   "author": "CamScanner",
   "pages": [
    373
   ]
  },
  {
   "title": "Cover",
   "author": "Vitalsource Download",
   "pages": [
    7687
   ]
  },
  {
   "title": "2021_Fleisher_&_Ludwig's_Textbook_of_Pediatric_Emergency_Medicine.epub",
   "author": null,
   "pages": []
  },
  {
   "title": "MedStudy Pediatrics Core 11th Edition 2024-2025",
   "author": null,
   "pages": [
    948
   ]
  },
  {
   "title": "Pediatric Clinical Practice Guidelines and Policies",
   "author": "American Academy of Pediatrics (AAP);",
   "pages": [
    506
   ]
  }
 ],
 "short": [
  {
   "title": "In short",
   "content": "- Obstructive sleep apnea syndrome (OSAS) is recurrent partial or complete upper airway obstruction during sleep, causing increased respiratory effort, disrupted sleep, and abnormal gas exchange; it exists on a continuum from benign primary snoring (regular snoring without apneas, arousals, or gas exchange abnormality) to full OSAS.\n- Prevalence documented by overnight sleep study is about 1\u20135% of children (sources cite 1\u20133% and 1\u20135%), peaking at ages 2\u20138 (specifically 2\u20136 years in some sources), coinciding with the time tonsils/adenoids are relatively largest compared to the upper airway.\n- Over 95% of pediatric OSAS is caused by structural airway obstruction (chiefly adenotonsillar hypertrophy); the remainder is neurologic in origin. Other disease associations: obesity, allergic rhinitis, laryngomalacia, mucopolysaccharidoses, Down syndrome, craniofacial syndromes, cerebral palsy, hypothyroidism, and nasal masses.\n- Key history features: frequent snoring (\u22653 nights/week), labored breathing during sleep, gasping/snorting or witnessed apnea episodes, sleep enuresis (especially secondary enuresis), sleeping seated or with neck hyperextended, cyanosis, morning headache, daytime sleepiness, ADHD-like symptoms, and learning problems.\n- Key exam findings: underweight or overweight, tonsillar hypertrophy, adenoidal facies, micrognathia/retrognathia, high-arched palate, failure to thrive, and hypertension.\n- Diagnosis is confirmed by polysomnography \u2014 an apnea-hypopnea index (AHI) of 1 or more per hour of sleep meets ICSD-3 criteria for pediatric OSA (though a total AHI cutoff below 1.5 is also commonly used in practice, given limited data supporting the ICSD-3 threshold); complications like elevated blood pressure are usually not seen until AHI reaches 5 or higher, and hypoxemia depth also matters independent of AHI.\n- Untreated OSAS can cause periodic hypoxemia, hypercarbia, neurocognitive impairment, behavioral problems, failure to thrive, cor pulmonale, pulmonary hypertension, systemic hypertension, and right-sided heart failure.\n- Polysomnography distinguishes primary snoring from true OSAS, determines severity, and can detect central sleep apnea, which changes management \u2014 this distinction matters because central apnea, unlike obstructive apnea, may not respond to adenotonsillectomy or standard OSA treatment.\n- Adenotonsillectomy is the primary treatment when adenotonsillar hypertrophy is the cause (also indicated for adenotonsillar hypertrophy causing speech defects, craniofacial growth abnormality, dysphagia, or cor pulmonale); continuous positive airway pressure (CPAP) is used for children who are not surgical candidates or who do not respond to surgery. Appropriate OSA treatment can improve behavior and cognitive function.\n- OSA and nocturnal asthma can overlap and mimic each other; evaluate for OSA in patients with unstable, poorly controlled asthma (especially if overweight/obese), since nasal CPAP improves outcomes in patients who truly have coexisting apnea, but can disrupt sleep in asthma patients without apnea \u2014 confirming the correct diagnosis before treating matters."
  }
 ],
 "long": [
  {
   "title": "Definition",
   "content": "Obstructive sleep-disordered breathing exists on a spectrum. Primary (habitual) snoring is regular snoring without significant obstructive apneas, frequent arousals, or gas exchange abnormalities \u2014 the most common but least worrisome end of the spectrum. Obstructive sleep apnea syndrome (OSAS) is at the more severe end: recurrent episodes of complete or partial upper airway obstruction during sleep, despite continued or increased respiratory effort, causing arousals, awakenings, and/or oxyhemoglobin desaturation. Formally, the International Classification of Sleep Disorders, Third Edition (ICSD-3) defines pediatric OSA as an apnea-hypopnea index (AHI) of 1 or more events per hour of sleep, or a pattern of obstructive hypoventilation (at least 25% of total sleep time with PaCO2 above 50 mmHg) occurring together with snoring, flattening of the nasal pressure waveform, or paradoxical respiratory effort \u2014 though limited data support this specific AHI cutoff, and a total AHI below 1.5 is also commonly used as a working threshold in practice. Sleep-disordered breathing more broadly includes central sleep apnea and obstructive hypoventilation as related but distinct entities."
  },
  {
   "title": "Epidemiology",
   "content": "OSAS is a common pediatric condition, with prevalence documented by overnight sleep studies estimated at roughly 1\u20135% of children (individual sources cite 1\u20133% or 1\u20135%), peaking between ages 2 and 8 years (with a narrower peak of 2\u20136 years cited in some sources). This peak likely reflects the relative size of the tonsils and adenoids compared with the upper airway at this stage of development."
  },
  {
   "title": "Etiology",
   "content": "More than 95% of pediatric OSAS cases result from structural airway obstruction, chiefly adenotonsillar hypertrophy, with the small remainder attributable to neurologic causes. Additional recognized disease associations include obesity, allergic rhinitis, laryngomalacia, mucopolysaccharidoses, Down syndrome, craniofacial syndromes, cerebral palsy, hypothyroidism, and nasal masses. Increased weight, anatomic airway abnormalities, and intercurrent upper respiratory infection can each provoke or worsen symptoms."
  },
  {
   "title": "Clinical features",
   "content": "Key historical features include frequent snoring (3 or more nights per week), labored breathing during sleep, gasping or snorting noises or witnessed apnea episodes, sleep enuresis (particularly secondary enuresis), sleeping in a seated position or with the neck hyperextended, cyanosis, headache on awakening, daytime sleepiness, attention-deficit/hyperactivity-like symptoms, and learning problems. Physical exam findings include being underweight or overweight, tonsillar hypertrophy, adenoidal facies, micrognathia or retrognathia, a high-arched palate, failure to thrive, and hypertension. Untreated OSAS carries substantial morbidity: periodic hypoxemia, hypercarbia, increased respiratory effort, intrathoracic pressure changes, neurocognitive impairment, behavioral problems, failure to thrive, and cor pulmonale; longer-term untreated disease can progress to pulmonary hypertension, systemic hypertension, and right-sided heart failure. OSA and nocturnal asthma symptoms can overlap and are frequently underdiagnosed together \u2014 a high prevalence of OSA has been reported specifically in patients with unstable, poorly controlled asthma, particularly those who are overweight or obese, and nasopharyngeal congestion from allergic rhinitis with resulting mouth breathing can worsen both conditions simultaneously."
  },
  {
   "title": "Diagnostics",
   "content": "Polysomnography (overnight sleep study) is the diagnostic procedure of choice and is essential for distinguishing benign primary snoring from true OSAS, determining disease severity, and detecting coexisting central sleep apnea \u2014 a distinction that matters because central apnea can change the management approach substantially. Diagnostic criteria use the apnea-hypopnea index: an AHI of 1 or more per hour meets ICSD-3 criteria for pediatric OSA, though a total AHI below 1.5 is also used in practice given limited supporting data for the stricter cutoff; clinically significant complications such as elevated blood pressure are usually not seen until AHI reaches 5 or higher, and the depth of hypoxemia should be considered alongside the AHI rather than in isolation. Diagnostic goals include identifying patients at risk for adverse outcomes, avoiding unnecessary intervention, evaluating which patients are at risk for complications, and specifically determining whether central sleep apneas are present. In a patient with unstable asthma and suspected OSA, confirming the diagnosis with polysomnography is important before initiating CPAP, since nasal CPAP improves outcomes in patients who truly have coexisting apnea, but can disrupt sleep in asthma patients who do not have apnea."
  },
  {
   "title": "Treatment",
   "content": "When adenotonsillar hypertrophy is the cause, adenotonsillectomy is the primary treatment; this is also indicated when adenotonsillar hypertrophy produces speech defects, craniofacial growth abnormality, dysphagia, failure to thrive, or cor pulmonale, and other tonsillectomy indications include recurrent acute tonsillitis, recurrent tonsillitis with valvular heart disease or recurrent febrile seizures, recurrent peritonsillar abscess, and infectious mononucleosis with severely obstructing tonsils refractory to medical management. For children who are not surgical candidates, or who do not respond adequately to surgery, continuous positive airway pressure (CPAP) is an effective option. Appropriately treating OSA can produce measurable improvements in behavior and cognitive abilities, underscoring the value of timely diagnosis and intervention rather than watchful waiting once OSAS is confirmed."
  }
 ],
 "clinical": [
  {
   "title": "Approach at the bedside",
   "content": "Screen for OSAS using the history and exam findings above whenever a child presents with habitual snoring, witnessed apnea, morning headache, daytime sleepiness, new-onset secondary enuresis, or ADHD-like symptoms/learning problems, and specifically examine for tonsillar hypertrophy, adenoidal facies, micrognathia, and growth parameters (failure to thrive or obesity), plus blood pressure. Refer for polysomnography to confirm the diagnosis and grade severity, rather than relying on history and exam alone, since these clinical features cannot reliably distinguish benign primary snoring from true OSAS, and polysomnography is also needed to detect coexisting central sleep apnea, which would change the management plan.\n\nFor a child with confirmed OSAS from adenotonsillar hypertrophy, refer for adenotonsillectomy as first-line treatment; add CPAP for children who are poor surgical candidates or who have persistent OSA after surgery. Counsel families that untreated OSAS carries real long-term risk \u2014 neurocognitive impairment, behavioral problems, failure to thrive, and, if severe and prolonged, cor pulmonale and systemic/pulmonary hypertension \u2014 and that appropriate treatment can meaningfully improve behavior and cognitive function, which supports timely referral rather than a wait-and-see approach.\n\nIn a child or adolescent with poorly controlled, unstable asthma \u2014 especially if overweight or obese \u2014 screen specifically for coexisting OSA, since the two conditions frequently overlap and untreated OSA can be contributing to asthma instability; confirm with polysomnography before starting CPAP, since CPAP helps genuine coexisting apnea but can disrupt sleep if apnea is not actually present. Manage allergic rhinitis and nasal congestion as a shared contributing factor when both conditions coexist, since nasopharyngeal congestion and resultant mouth breathing can worsen both asthma and OSA together."
  }
 ]
}